Offer - Urjas Oil for just ₹ 1 X
Evarab DSR is an allopathic medicine The correct dosage of Evarab DSR depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Evarab DSR is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Evarab DSR safe for pregnant women?
Pregnant women can take Evarab DSR safely.
Is the use of Evarab DSR safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Evarab DSR . Immediately discontinue Evarab DSR if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Evarab DSR on the Kidneys?
There are no side effects of Evarab DSR on the kidneys.
What is the effect of Evarab DSR on the Liver?
Very few cases of side effects of Evarab DSR on the liver have been reported.
What is the effect of Evarab DSR on the Heart?
Evarab DSR is not harmful for the heart.
Evarab DSR should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Evarab DSR unless your doctor advises you to do so -
Is this Evarab DSR habit forming or addictive?
Evarab DSR does not cause addiction.
Interaction between Food and Evarab DSR
It is safe to take Evarab DSR with food.
Interaction between Alcohol and Evarab DSR
Consuming Evarab DSR with alcohol can have many serious effects on your body.
Ideally, Evarab DSR should be taken by mouth once daily but it can be taken twice in some cases depending on the severity of symptoms or as advised by your doctor. It should be taken before 30 minutes of eating food to prevent acidity and heartburn. Precautions must be taken in patients with hypersensitivity and improper liver function.
Evarab DSR is a prescription drug, hence do not take it without consulting doctor. It can be harmful for patients to take this medicine without a doctor's advice.
Yes, Evarab DSR has been reported to cause rashes or itching but this occurs in a few cases only. It is a common side effect of this medicine. If you experience excessive itching then consult it with your doctor immediately.
Yes, Evarab DSR can cause headache, this occurs rarely. It is a known side effect of this drug. However, the exact cause behind this is unknown. If you experience severe headache after taking this drug, consider taking a mild painkiller, applying balms and complete rest, even after this if pain does not subside then discuss with your doctor immediately.
No, Evarab DSR does not causes bloating (swollen belly after eating food which might be caused by excessive gas production). It has not been reported by the patients who are taking it. If you are experiencing bloating after taking this medicine, then try eating less spicy and fibre rich food also try to eat food in less quantity at a time. Taking probiotics or digestive enzyme supplements might be helpful in reducing bloating.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 666-667
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1310-1311
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aciphex® (rabeprazole sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1077-1078